Targeting MicroRNA-485-3p Blocks Alzheimer’s Disease Progression

Alzheimer’s disease (AD) is a form of dementia characterized by progressive memory decline and cognitive dysfunction. With only one FDA-approved therapy, effective treatment strategies for AD are urgently needed. In this study, we found that microRNA-485-3p (miR-485-3p) was overexpressed in the brai...

Descripción completa

Detalles Bibliográficos
Autores principales: Koh, Han Seok, Lee, SangJoon, Lee, Hyo Jin, Min, Jae-Woong, Iwatsubo, Takeshi, Teunissen, Charlotte E., Cho, Hyun-Jeong, Ryu, Jin-Hyeob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658496/
https://www.ncbi.nlm.nih.gov/pubmed/34884940
http://dx.doi.org/10.3390/ijms222313136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658496/
https://www.ncbi.nlm.nih.gov/pubmed/34884940
http://dx.doi.org/10.3390/ijms222313136

Ejemplares similares